Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird from extinction. What are the ...

Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

The paper mill was discovered by the research-integrity sleuth and scientist Anna Abalkina at the Free University of Berlin ...

A company that hardly needs an introduction is Eli Lilly, but what has it been up to lately, and what’s its pipeline strategy? Over the past year, Lilly has mixed headline-grabbing science with ...

Learn why rare diseases are more common in some communities due to cousin marriages and founder effects in population ...

A couple of months ago, we covered two big funding rounds in the span of two days in radiopharma, Nuclidium’s and Actithera’s. Fast forward to today, and the field is showing absolutely no sign of ...

First, let’s take a look at the private biotech investments in August 2025, breaking them down by value, location, funding type, and therapeutic subsector. In August 2025, not only did gene therapy ...

On September 4, 2025, the U.S. Food and Drug Administration (FDA) published a new batch of 89 Complete Response Letters (CRLs) as part of its ongoing transparency initiative. Among them was the CRL ...